2-(Trifluoromethoxy)benzoic acid | CAS:1979-29-9

We serve 2-(Trifluoromethoxy)benzoic acid CAS:1979-29-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-(Trifluoromethoxy)benzoic acid

Chemical Name:2-(Trifluoromethoxy)benzoic acid
CAS.NO:1979-29-9
Synonyms:2-(Trifluoromethoxy)benzoic acid
o-trifluoromethoxybenzoic acid
2-TtrifluoroMethoxybenzoicacid
Molecular Formula:C8H5F3O3
Molecular Weight:206.11900
 
Physical and Chemical Properties:
Density:1.206
Melting point:78ºC
Boiling point:190.7ºC
Flash point:70.3ºC
 
Specification:
Appearance:White to light yellow crystalline powder
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-(Trifluoromethoxy)benzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-TtrifluoroMethoxybenzoicacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-TtrifluoroMethoxybenzoicacid Use and application,2-TtrifluoroMethoxybenzoicacid technical grade,usp/ep/jp grade.


Related News: The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.2,6-Difluoropyridine manufacturer Health officials said it remained unclear where he had developed the disease.L-Homoserine supplier Health officials said it remained unclear where he had developed the disease.4-fluorobutyl acetate vendor High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.